首页 | 本学科首页   官方微博 | 高级检索  
     


Gender and BCR‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia
Authors:Han‐Xin Lin  Jenny Sjaarda  Jocob Dyck  Randa Stringer  Chris Hillis  Maria Harvey  Ronald Carter  Peter Ainsworth  Brian Leber  Guillaume Pare  Bekim Sadikovic
Affiliation:1. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada;2. Hamilton Regional Laboratory Medicine Program, Hamilton Health Science, Hamilton, ON, Canada;3. Department of Oncology, McMaster University, Juravinski Hospital, Hamilton, ON, Canada;4. Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada;5. Molecular Genetics Laboratory, London Health Sciences Centre, London, ON, Canada;6. Population Health Research Institute, Hamilton Health Sciences, McMaster University;7. McMaster University, Hamilton, ON, Canada;8. Population Genomics Program, Chanchlani Research Centre, McMaster University;9. Department of Clinical Epidemiology and Biostatistics, McMaster University;10. Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada
Abstract:
Keywords:chronic myeloid leukemia     BCR‐ABL     gender  imatinib  major molecular response
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号